快速玻璃化联合快速复苏对冻融胚胎移植活产结局的影响
该回顾性队列研究比较三种玻璃化/复苏方案组合下首次单囊胚冻融胚胎移植的妊娠结局,共纳入标准玻璃化-标准复苏1025例、标准玻璃化-快速复苏926例、快速玻璃化-快速复苏471例。未校正与校正分析均显示各组活产率、妊娠率、生化妊娠率、临床妊娠率及自然流产率无差异,PGT-A胚胎亚组活产率亦无差异。
要点
- 快速玻璃化联合快速复苏方案的活产率与标准方案相当,未见负面影响。
- 未校正分析各组活产率42.5%、41.8%、46.9%,P=0.167,差异无统计学意义。
- PGT-A胚胎亚组活产率45.1%、46.2%、49.6%,P=0.472,同样无差异。
核心结论
- 快速玻璃化联合快速复苏方案对冻融囊胚的活产结局与标准玻璃化联合标准复苏方案同样有效,未显示负面影响。
研究设计与样本
- 回顾性比较队列研究,纳入接受自然、药物或程序化周期单囊胚冻融胚胎移植的独立患者,每组仅纳入 fresh 周期后首次冻融胚胎移植。
- 共三组:标准玻璃化-标准复苏n=1025,标准玻璃化-快速复苏n=926,快速玻璃化-快速复苏n=471。
- 采用逻辑回归模型校正冻存日(第5天或第6天)、冻融胚胎移植准备方案、体质量指数及卵母细胞年龄,并对行PGT-A的胚胎进行亚组分析。
主要发现
- 未校正分析各组活产率分别为42.5%、41.8%、46.9%(P=0.167),妊娠率58.8%、56.3%、62.4%(P=0.085),生化妊娠率8.9%、8.1%、8.5%(P=0.827)。
- 未校正分析各组临床妊娠率49.6%、48.1%、53.3%(P=0.179),自然流产率6.9%、6.0%、6.2%(P=0.704)。
- 校正分析后上述结果保持不变。
- PGT-A胚胎亚组活产率分别为45.1%(n=548)、46.2%(n=424)、49.6%(n=266),P=0.472,组间无差异。
关键数值与推荐
- 主要结局为活产率,次要结局包括阳性妊娠试验率、生化妊娠率、临床妊娠率及流产率。
- PGT-A胚胎亚组中三种方案组合的活产率无显著差异(P=0.472)。
临床怎么用
- 对于冻融囊胚移植,快速玻璃化联合快速复苏可作为与标准方案等效的实验室操作选择。
- 选择方案时可结合实验室流程效率考虑,现有数据未提示快速方案会降低活产或增加流产风险。
局限性
- 本研究为回顾性队列研究,非随机设计,可能存在未校正的混杂因素。
- 仅纳入首次冻融单囊胚移植患者,结果外推至其他人群需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: Does the combination of fast vitrification and fast warming protocols, compared with standard vitrification and standard warming protocols, result in differences in pregnancy outcomes following frozen embryo transfer (FET)? DESIGN: This was a retrospective comparative cohort study of unique patients undergoing either natural, medicated or programmed FET cycles of single blastocysts. The first FET following fresh cycles was included for each patient. Three groups were analysed: standard vitrification with standard warming protocol (n = 1025); standard vitrification with fast warming protocol (n = 926); and fast vitrification with fast warming protocol (n = 471). The primary outcome was live birth rate. Secondary outcomes included positive pregnancy test rate, biochemical pregnancy rate, clinical pregnancy rate and miscarriage rate. Logistic regression models were performed, controlling for day of cryopreservation (day 5 or day 6), FET preparation, body mass index and oocyte age. A subanalysis was performed on embryos that underwent preimplantation genetic testing for aneuploidy (PGT-A). RESULTS: Unadjusted analysis showed no difference in live birth rate (42.5% versus 41.8% versus 46.9%; P = 0.167), pregnancy rate (58.8% versus 56.3% versus 62.4%; P = 0.085), biochemical pregnancy rate (8.9% versus 8.1% versus 8.5%; P = 0.827), clinical pregnancy rate (49.6% versus 48.1% versus 53.3%; P = 0.179), and spontaneous abortion rate (6.9% versus 6.0% versus 6.2%; P = 0.704) across the standard vitrification-standard warming, standard vitrification-fast warming, and fast vitrification-fast warming groups, respectively. These findings remained unchanged in the adjusted analysis. A subanalysis of PGT-A embryos showed no difference in live birth rate (45.1% versus 46.2% versus 49.6%; P = 0.472) between the standard vitrification-standard warming (n = 548), standard vitrification-fast warming (n = 424), and fast vitrification-fast warming (n = 266) groups, respectively. CONCLUSIONS: The fast vitrification-fast warming protocol for vitrified and warmed blastocyst-stage embryos is as effective as the standard vitrification-standard warming protocol, demonstrating no negative impact on live birth or secondary outcomes.
引用
- Arkfeld CK, Vagios S, Minis EE, et al. Impact of combining fast vitrification and fast warming protocols on live birth outcomes. Reprod Biomed Online. 2026. PMID: 42669220. doi:10.1016/j.rbmo.2026.105897
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。